And in patients with NASH, hepatic expression level of p21 is significantly higher than patients with simple steatosis [18], [19] and impaired hepatocyte replication by p21 expression correlates with insulin resistance and inflammatory activity [19]. Here, CDKN1A is linked to metabolic dysfunction-associated steatohepatitis.